CARDIOVASCULAR GENOMIC MEDICINE
Role of Genetic Analysis in the Management of Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Srijita Sen-Chowdhry, MBBS, MD, MRCP,
Petros Syrris, BSc, PhD and
William J. McKenna, MD, DSc, FRCP, FACC*
Cardiology in the Young, The Heart Hospital, University College London, London, United Kingdom
Manuscript received May 3, 2007;
revised manuscript received July 2, 2007,
accepted August 6, 2007.
* Reprint requests and correspondence: Dr. William J. McKenna, Cardiology in the Young, The Heart Hospital, 16-18 Westmoreland Street, London W1G 8PH, United Kingdom. (Email: william.mckenna{at}uclh.nhs.uk).
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a recognized cause of sudden cardiac death, which may be prevented by timely detection and intervention. Clinical diagnosis of ARVC is fraught with difficulties in both index cases and relatives owing to the nonspecific nature of associated features, diverse phenotypic manifestations, and a lack of conspicuous abnormalities in the early, "concealed" phase. During the past 7 years, researchers have isolated causative mutations in several components of the desmosome, shedding light on the molecular mechanisms underlying the disease and offering the promise of genetic testing as a diagnostic tool. Sequence analysis is likely to be the mainstay of genotyping in ARVC because of marked allelic heterogeneity, frequent "private" mutations, and digenicity in a minority, highlighting the importance of comprehensive genetic screening. The main technical obstacle to implementation of genotyping in clinical practice will be the prohibitive costs of performing sequence analysis of a genomic region exceeding 40 kb. Nevertheless, the success rate of genotyping in ARVC is of the order of 40%, and key clinical applications include confirmatory testing of index cases to facilitate interpretation of borderline investigations and cascade screening of families. The latter is particularly attractive in ARVC, because age-related penetrance otherwise demands lifelong clinical reassessment of extended families. A role for genetic analysis in prognostication is more tenuous at present, but increasing identification of individuals with early and familial disease underscores the need for a definitive risk stratification algorithm in this population.
|
Abbreviations and Acronyms
| | ARVD/C = arrhythmogenic right ventricular dysplasia/ cardiomyopathy | | ICD = implantable cardioverter-defibrillator | | PKP = plakophilin | | TGF = transforming growth factor |
|
This article has been cited by other articles:
|
|
|
|
 
J. Gomes, M. Finlay, A. K. Ahmed, E. J. Ciaccio, A. Asimaki, J. E. Saffitz, G. Quarta, M. Nobles, P. Syrris, S. Chaubey, et al.
Electrophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-A combined murine and human study
Eur. Heart J.,
January 11, 2012;
(2012)
ehr472v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Taylor, S. Graw, G. Sinagra, C. Barnes, D. Slavov, F. Brun, B. Pinamonti, E. E. Salcedo, W. Sauer, S. Pyxaras, et al.
Genetic Variation in Titin in Arrhythmogenic Right Ventricular Cardiomyopathy-Overlap Syndromes
Circulation,
August 23, 2011;
124(8):
876 - 885.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Ackerman, S. G. Priori, S. Willems, C. Berul, R. Brugada, H. Calkins, A. J. Camm, P. T. Ellinor, M. Gollob, R. Hamilton, et al.
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
Europace,
August 1, 2011;
13(8):
1077 - 1109.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Kapplinger, A. P. Landstrom, B. A. Salisbury, T. E. Callis, G. D. Pollevick, D. J. Tester, M. G. P. J. Cox, Z. Bhuiyan, H. Bikker, A. C. P. Wiesfeld, et al.
Distinguishing Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia-Associated Mutations From Background Genetic Noise
J. Am. Coll. Cardiol.,
June 7, 2011;
57(23):
2317 - 2327.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. I. Sarvari, K. H. Haugaa, O.-G. Anfinsen, T. P. Leren, O. A. Smiseth, E. Kongsgaard, J. P. Amlie, and T. Edvardsen
Right ventricular mechanical dispersion is related to malignant arrhythmias: a study of patients with arrhythmogenic right ventricular cardiomyopathy and subclinical right ventricular dysfunction
Eur. Heart J.,
May 1, 2011;
32(9):
1089 - 1096.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Corrado, C. Basso, K. Pilichou, and G. Thiene
Molecular biology and clinical management of arrhythmogenic right ventricular cardiomyopathy/dysplasia
Heart,
April 1, 2011;
97(7):
530 - 539.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Gehmlich, P. Syrris, E. Peskett, A. Evans, E. Ehler, A. Asimaki, A. Anastasakis, A. Tsatsopoulou, A.-I. Vouliotis, C. Stefanadis, et al.
Mechanistic insights into arrhythmogenic right ventricular cardiomyopathy caused by desmocollin-2 mutations
Cardiovasc Res,
April 1, 2011;
90(1):
77 - 87.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Kim, R. B. Devereux, and C. T. Basson
Impact of Genetic Insights Into Mendelian Disease on Cardiovascular Clinical Practice
Circulation,
February 8, 2011;
123(5):
544 - 550.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Limongelli and P. M. Elliott
5 The genetics of heart failure
Oxford Textbook of Heart Failure,
January 1, 2011;
1(1):
med-9780199577729-chapter - med-9780199577729-chapter.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
P. Charron, M. Arad, E. Arbustini, C. Basso, Z. Bilinska, P. Elliott, T. Helio, A. Keren, W. J. McKenna, L. Monserrat, et al.
Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Eur. Heart J.,
November 2, 2010;
31(22):
2715 - 2726.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. V. Raman, C. Basso, H. Tandri, and M. R. G. Taylor
Imaging Phenotype vs Genotype in Nonhypertrophic Heritable Cardiomyopathies: Dilated Cardiomyopathy and Arrhythmogenic Right Ventricular Cardiomyopathy
Circ Cardiovasc Imaging,
November 1, 2010;
3(6):
753 - 765.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Kimura, Y. Matsuo, T. Nakajima, T. Nishikawa, S. Kawamura, S. Sannohe, N. Hagiwara, and F. Sakai
Myocardial Fat at Cardiac Imaging: How Can We Differentiate Pathologic from Physiologic Fatty Infiltration?
RadioGraphics,
October 1, 2010;
30(6):
1587 - 1602.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Corrado, H. Calkins, M. S. Link, L. Leoni, S. Favale, M. Bevilacqua, C. Basso, D. Ward, G. Boriani, R. Ricci, et al.
Prophylactic Implantable Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia and No Prior Ventricular Fibrillation or Sustained Ventricular Tachycardia
Circulation,
September 21, 2010;
122(12):
1144 - 1152.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Delmar and W. J. McKenna
The Cardiac Desmosome and Arrhythmogenic Cardiomyopathies: From Gene to Disease
Circ. Res.,
September 17, 2010;
107(6):
700 - 714.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Elliott, C. O'Mahony, P. Syrris, A. Evans, C. Rivera Sorensen, M. N. Sheppard, G. Carr-White, A. Pantazis, and W. J. McKenna
Prevalence of Desmosomal Protein Gene Mutations in Patients With Dilated Cardiomyopathy
Circ Cardiovasc Genet,
August 1, 2010;
3(4):
314 - 322.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Sen-Chowdhry, P. Syrris, A. Pantazis, G. Quarta, W. J. McKenna, and J. C. Chambers
Mutational Heterogeneity, Modifier Genes, and Environmental Influences Contribute to Phenotypic Diversity of Arrhythmogenic Cardiomyopathy
Circ Cardiovasc Genet,
August 1, 2010;
3(4):
323 - 330.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. La Gerche, C. Robberecht, C. Kuiperi, D. Nuyens, R. Willems, T. de Ravel, G. Matthijs, and H. Heidbuchel
Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin
Heart,
August 1, 2010;
96(16):
1268 - 1274.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Fressart, G. Duthoit, E. Donal, V. Probst, J. C. Deharo, P. Chevalier, D. Klug, O. Dubourg, E. Delacretaz, P. Cosnay, et al.
Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice
Europace,
June 1, 2010;
12(6):
861 - 868.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. E. Hershberger, N. Norton, A. Morales, D. Li, J. D. Siegfried, and J. Gonzalez-Quintana
Coding Sequence Rare Variants Identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 From 312 Patients With Familial or Idiopathic Dilated Cardiomyopathy
Circ Cardiovasc Genet,
April 1, 2010;
3(2):
155 - 161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. den Haan, B. Y. Tan, M. N. Zikusoka, L. I. Llado, R. Jain, A. Daly, C. Tichnell, C. James, N. Amat-Alarcon, T. Abraham, et al.
Comprehensive Desmosome Mutation Analysis in North Americans With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Circ Cardiovasc Genet,
October 1, 2009;
2(5):
428 - 435.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. A. Bhuiyan, J. D.H. Jongbloed, J. van der Smagt, P. M. Lombardi, A. C.P. Wiesfeld, M. Nelen, M. Schouten, R. Jongbloed, M. G.P.J. Cox, M. van Wolferen, et al.
Desmoglein-2 and Desmocollin-2 Mutations in Dutch Arrhythmogenic Right Ventricular Dysplasia/Cardiomypathy Patients: Results From a Multicenter Study
Circ Cardiovasc Genet,
October 1, 2009;
2(5):
418 - 427.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Krahn, J. S. Healey, V. Chauhan, D. H. Birnie, C. S. Simpson, J. Champagne, M. Gardner, S. Sanatani, D. V. Exner, G. J. Klein, et al.
Systematic Assessment of Patients With Unexplained Cardiac Arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER)
Circulation,
July 28, 2009;
120(4):
278 - 285.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. E. Hershberger, J. Cowan, A. Morales, and J. D. Siegfried
Progress With Genetic Cardiomyopathies: Screening, Counseling, and Testing in Dilated, Hypertrophic, and Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Circ Heart Fail,
May 1, 2009;
2(3):
253 - 261.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. G. Priori, C. Napolitano, S. E. Humphries, and J. Skipworth
CHAPTER 9 Genetics of Cardiovascular Diseases
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Sen-Chowdhry, P. Syrris, S. K. Prasad, S. E. Hughes, R. Merrifield, D. Ward, D. J. Pennell, and W. J. McKenna
Left-Dominant Arrhythmogenic Cardiomyopathy: An Under-Recognized Clinical Entity
J. Am. Coll. Cardiol.,
December 16, 2008;
52(25):
2175 - 2187.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
